Search research articles
Contact Us
Filters
Showing results (81-90 of 86) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 86 results.
Seminars in Nephrology
|
December 1, 1987
IgA-associated renal diseases: immunochemical studies of IgA1 proteins, circulating immune complexes, and cellular interactions
J Mestecky, M Tomana, C Czerkinsky, et al.
Vaccine
|
April 20, 2001
A Phase I safety and immunogenicity trial of UBI microparticulate monovalent HIV-1 MN oral peptide immunogen with parenteral boost in HIV-1 seronegative human subjects
J S Lambert, M Keefer, M J Mulligan, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
June 8, 2001
Biodegradable block copolymers for delivery of proteins and water-insoluble drugs
G M Zentner, R Rathi, C Shih, et al.
Scandinavian Journal of Immunology
|
April 1, 1992
Properties of IgA-binding receptors on murine T cells: relative importance of Fc alpha R, beta-galactosyltransferase and anti-secretory component reactive proteins (ASCP)
W K Aicher, M L McGhee, J R McGhee, et al.
Kidney International
|
March 8, 2007
Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels
Z Moldoveanu, R J Wyatt, J Y Lee, et al.
Mucosal Immunology
|
May 7, 2015
Chemokine-adjuvanted electroporated DNA vaccine induces substantial protection from simian immunodeficiency virus vaginal challenge
M A Kutzler, M C Wise, N A Hutnick, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 86) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 86 results.
Seminars in Nephrology
|
December 1, 1987
IgA-associated renal diseases: immunochemical studies of IgA1 proteins, circulating immune complexes, and cellular interactions
J Mestecky, M Tomana, C Czerkinsky, et al.
Vaccine
|
April 20, 2001
A Phase I safety and immunogenicity trial of UBI microparticulate monovalent HIV-1 MN oral peptide immunogen with parenteral boost in HIV-1 seronegative human subjects
J S Lambert, M Keefer, M J Mulligan, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
June 8, 2001
Biodegradable block copolymers for delivery of proteins and water-insoluble drugs
G M Zentner, R Rathi, C Shih, et al.
Scandinavian Journal of Immunology
|
April 1, 1992
Properties of IgA-binding receptors on murine T cells: relative importance of Fc alpha R, beta-galactosyltransferase and anti-secretory component reactive proteins (ASCP)
W K Aicher, M L McGhee, J R McGhee, et al.
Kidney International
|
March 8, 2007
Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels
Z Moldoveanu, R J Wyatt, J Y Lee, et al.
Mucosal Immunology
|
May 7, 2015
Chemokine-adjuvanted electroporated DNA vaccine induces substantial protection from simian immunodeficiency virus vaginal challenge
M A Kutzler, M C Wise, N A Hutnick, et al.
Page
of 9